IL100452A - Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist - Google Patents

Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist

Info

Publication number
IL100452A
IL100452A IL10045291A IL10045291A IL100452A IL 100452 A IL100452 A IL 100452A IL 10045291 A IL10045291 A IL 10045291A IL 10045291 A IL10045291 A IL 10045291A IL 100452 A IL100452 A IL 100452A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonist
effervescent pharmaceutical
effervescent
Prior art date
Application number
IL10045291A
Other languages
English (en)
Other versions
IL100452A0 (en
Inventor
Alain Emile Edouard Schaeffer
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of IL100452A0 publication Critical patent/IL100452A0/xx
Publication of IL100452A publication Critical patent/IL100452A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL10045291A 1990-12-21 1991-12-20 Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist IL100452A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (2)

Publication Number Publication Date
IL100452A0 IL100452A0 (en) 1992-09-06
IL100452A true IL100452A (en) 1997-02-18

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10045291A IL100452A (en) 1990-12-21 1991-12-20 Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist

Country Status (25)

Country Link
EP (1) EP0563094B1 (cs)
JP (1) JP3425949B2 (cs)
KR (1) KR100188172B1 (cs)
AT (1) ATE127688T1 (cs)
AU (1) AU654313B2 (cs)
BE (1) BE1004182A3 (cs)
CA (1) CA2099585C (cs)
CH (1) CH684161A5 (cs)
CZ (1) CZ281042B6 (cs)
DE (1) DE69113062T2 (cs)
DK (1) DK0563094T3 (cs)
ES (1) ES2078727T3 (cs)
FR (1) FR2670674B1 (cs)
GB (2) GB9027827D0 (cs)
GR (1) GR3017701T3 (cs)
HK (1) HK18795A (cs)
IE (1) IE914482A1 (cs)
IL (1) IL100452A (cs)
IT (1) IT1252599B (cs)
MX (1) MX9102733A (cs)
NZ (1) NZ241098A (cs)
RU (1) RU2110992C1 (cs)
SG (1) SG169594G (cs)
WO (1) WO1992011003A1 (cs)
ZA (1) ZA9110052B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
GB9126957D0 (en) 1992-02-19
ATE127688T1 (de) 1995-09-15
ITRM910963A1 (it) 1993-06-20
AU654313B2 (en) 1994-11-03
JPH06503826A (ja) 1994-04-28
DK0563094T3 (da) 1995-12-04
FR2670674B1 (fr) 1994-05-13
MX9102733A (es) 1992-09-01
EP0563094B1 (en) 1995-09-13
ITRM910963A0 (it) 1991-12-20
CA2099585A1 (en) 1992-06-22
GB2250917A (en) 1992-06-24
JP3425949B2 (ja) 2003-07-14
GR3017701T3 (en) 1996-01-31
HK18795A (en) 1995-02-17
SG169594G (en) 1995-04-28
EP0563094A1 (en) 1993-10-06
IL100452A0 (en) 1992-09-06
CH684161A5 (fr) 1994-07-29
WO1992011003A1 (en) 1992-07-09
ZA9110052B (en) 1992-10-28
IT1252599B (it) 1995-06-19
DE69113062T2 (de) 1996-02-01
IE914482A1 (en) 1992-07-01
DE69113062D1 (de) 1995-10-19
FR2670674A1 (fr) 1992-06-26
GB9027827D0 (en) 1991-02-13
BE1004182A3 (fr) 1992-10-06
KR100188172B1 (ko) 1999-06-01
CZ281042B6 (cs) 1996-06-12
GB2250917B (en) 1994-10-26
NZ241098A (en) 1993-07-27
CA2099585C (en) 2003-09-30
ES2078727T3 (es) 1995-12-16
RU2110992C1 (ru) 1998-05-20
CZ122593A3 (en) 1994-02-16
AU9066591A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
TW215434B (cs)
SE8700498D0 (sv) Novel pharmaceologically active compounds
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
ZA832292B (en) Salicylic acid derivatives,processes for their preparation,pharmaceutical for mulations based on these compounds and their use
IL100452A (en) Effervescent pharmaceutical compositions containing 5HT1-like receptor antagonist
PH18186A (en) Isoquinoline derivatives,a process for their preparation pharmaceutical formulations based on these compounds and the use thereof
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
ES2164168T3 (es) Antagonistas de receptores de fibrinogeno que tienen residuos de beta-aminoacido sustituidos y composiciones farmaceuticas que comprenden los mismos.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
UA27784C2 (uk) Шипуча фармацевтична композиція для орального введення
IL89126A0 (en) Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
IT1273528B (it) Agonisti del recettore a3 della adenosina e composizioni farmaceutiche che li contengono
IT1252568B (it) Derivati pirimidinici sostituiti da eteroarili ad attivita' a ii antagonista
ITPD920141A1 (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina
IT1254565B (it) Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
CO4930293A1 (es) Derivados de 5-triazolil-2,3(1h,4h)-quinoxalinadiona que son antagonistas selectivos de receptores de n-metil-d-aspartato

Legal Events

Date Code Title Description
NP Permission for amending the patent specification granted (section 66, patents law 1967)
CB Opposition filed against grant of patent
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees